Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Investigation of Donor-Transmitted Strongyloides stercoralis Infections in Solid Organ Transplant Recipients, United States, 2012-2024.

Emerging infectious diseases·2026

Same author

Donor-Derived Cell-Free DNA as a Prognostic Biomarker After Heart Transplantation: The DEFINE-HT Study.

JACC. Heart failure·2026

Same author

Safety and Feasibility of IVC Flow Modulation With the Doraya in Acute Decompensated Heart Failure.

JACC. Heart failure·2026

Same author

Impact of "Door-to-Lactate Clearance" on Clinical Outcomes in Cardiogenic Shock.

JACC. Heart failure·2026

Same author

Short-Term Care Burden After Left Ventricular Assist Device Implantation and Heart Transplant in the United States.

Journal of the American Heart Association·2026

Same author

Comparison of Different SCAI SHOCK Stage Classification Systems in Patients With Cardiogenic Shock.

Journal of the Society for Cardiovascular Angiography & Interventions·2026

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

Induction therapy in cardiac transplantation: when and why?

David A Baran¹

¹Newark Beth Israel Medical Center, Newark, NJ 07112, USA. dbaran@sbhcs.com

Heart Failure Clinics

|June 5, 2007

Summary

Induction therapy in heart transplantation is controversial. Evidence suggests avoiding it unless benefits clearly outweigh risks, as there are no "free lunches" in immunosuppression.

Area of Science:

Cardiology
Immunosuppression
Transplantation Medicine

Background:

Induction therapy in heart transplantation has been debated for over two decades.
It is often considered a logical approach to immunosuppression post-transplant.

Purpose of the Study:

To critically review the evidence surrounding induction therapy in heart transplantation.
To evaluate the risk-benefit profile of induction therapy in this patient population.

Main Methods:

Systematic review and critical analysis of existing clinical evidence on induction therapy in heart transplantation.
Assessment of short-term and long-term risks versus benefits.

Main Results:

Current evidence does not consistently support the routine use of induction therapy.

More Related Videos

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Related Experiment Videos

Last Updated: Jul 14, 2026

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

The benefits of induction therapy do not always outweigh its associated risks.

Conclusions:

Induction therapy should be reserved for select heart transplant recipients where benefits demonstrably exceed risks.
Clinicians must fully comprehend the implications and risks before administering induction therapy.